STRANDDX Trademark
STRANDDX is a USPTO trademark filed by Linus Biotechnology Inc.. Status: Pending.
Trademark Facts
| Mark | STRANDDX |
|---|---|
| Serial Number | 99287105 |
| Status | Pending |
| Filing Date | 2025-07-16 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 009 (Electronics & Software), 042 (Software & IT), 044 (Medical Services) |
| Owner | Linus Biotechnology Inc. |
| Attorney of Record | Michael R Rizzo |
| Prosecution Events | 11 |
| Latest Event | DOCK on 2026-04-13 |
Goods & Services
Laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples; Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes; Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-20 | Amendment and Mail Process Complete | AMC |
| 2026-02-19 | Response to Office Action | ROA |
| 2025-12-04 | Non-Final Action | NFIN |
| 2025-12-04 | XSearch Search Summary | XSS |
| 2025-07-16 | Application | APP |
USPTO Refusals on Record
- indefinite_identification